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Editors: Anton N. Sidawy and Bruce A. PerlerThe impact of adjusting for reliability on hospital quality rankings in
vascular surgery
Nicholas H. Osborne, Clifford Y. Ko, Gilbert R. Upchurch, Justin B. Dimick
Background: Hospital quality in vascular surgery is often measured using
mortality. We sought to determine whether adjusting mortality for statis-
tical reliability changes hospital quality rankings for vascular surgery.
Methods: Patients undergoing five common vascular surgery procedures
(open and endovascular abdominal aortic aneurysm repair, carotid endarter-
ectomy, lower extremity bypass, and aorto-femoral bypass) in the National
Surgical Quality Improvement Project (NSQIP) in 2007 were identified (n =
14,559). For each hospital, we first calculated a ratio of observed to
expected mortality (O-E ratio) using standard NSQIP techniques. We then
adjusted these estimates for statistical noise using empirical Bayes methods,
a technique known as reliability adjustment. We then compared rankings
based on the standard O-E ratio to the rankings after reliability adjustment.
Results: A total of 172 hospitals reported an average adjusted mortality rate
of 2.4% for the five procedures, varying from 0% to 17%. After adjusting for
statistical noise using reliability adjustment, hospital mortality was greatly
diminished, varying only from 1.7% to 4.1%. This adjustment for reliability
had a dramatic effect on hospital rankings. Overall, 43% of hospitals were re-
classified into either a higher or lower quartile of performance using tradi-
tional methods of risk-adjustment. Fifty-one percent all hospitals in the
‘‘best’’ quartile of performance according to traditional O-E ratios are not
classified in the ‘‘best’’ quartile after adjusting for statistical noise.
Twenty-six percent of hospitals in the ‘‘worst’’ quartile were no longer clas-
sified as such after adjusting for noise.
Conclusions: Adjusting mortality for reliability reduces statistical noise and
provides more stable estimates of hospital quality. Reliability adjustment
should be standard for comparing hospital quality.Treatment options for delayed AAA rupture following endovascular repair
Manish Mehta, Philip S.K. Paty, Sean P. Roddy, John B. Taggert, Yaron
Sternbach, Paul B. Kreienberg, Benjamin B. Chang, R. Clement Darling III
Purpose: Delayed abdominal aortic aneurysm (AAA) rupture is a well recog-
nized complication of endovascular aneurysm repair (EVAR). We wanted to
evaluate the frequency, etiology, and outcomes of delayed AAA rupture
following EVAR, and identify treatment options that facilitate improved
survival.
Methods: From 2002 to 2009, 1768 patients underwent elective and emer-
gent EVAR. At a mean follow-up of 29 months, 27 (1.5%) patients presented
with delayed AAA rupture and required repair by either open surgical
conversion or endovascular means. All data were prospectively collected
in a vascular registry, and outcomes analyzed.
Results:: Over a mean follow-up of 29 months, the incidence of delayed AAA
rupture after elective EVAR was 1.4% (24 of 1615 patients), and after* Full articles available online at www.jvascsurg.org
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doi:10.1016/S1078-5884(10)00728-8emergent EVAR for ruptured AAA was 2.8% (3 of 106 patients). Of the 27 de-
layed AAA rupture patients, 20 (74%) were considered ‘‘lost to follow-up,’’
and, at presentation, 17 (63%) patients had Type 1 endoleak with stent graft
migration, three (11%) had Type 1 endoleak without stent graft migration,
five (19%) had Type 2 endoleak, and two (7%) had undetermined etiology
for aneurysm rupture. Fifteen (55%) patients underwent open surgical repair
via retroperitoneal approach with partial (n = 8; 53%) or complete (n = 7;
47%) stent graft explants and aortoiliac reconstruction, 11 (41%) patients
underwent a second EVAR, and one (4%) patient refused treatment and died.
Supraceliac aortic clamp was required in three (20%) patients with open
surgical conversion, and supraceliac occlusion balloon was required in two
(18%) patients with EVAR. There were three (11%) postoperative deaths;
two following open surgical conversion and one following EVAR. One addi-
tional redo-EVAR patient has undergone successful elective conversion to
open surgical repair for persistent type II endoleak and increase in AAA size.
Conclusions: Delayed AAA rupture following EVAR can be successfully
managed in most patients by open surgical conversion or secondary EVAR.
The approach to each patient should be individualized; complete stent graft
explant is not necessary in most patients; a secondary EVAR for delayed AAA
rupture with or without an elective conversion to open surgical repair
remains a viable option. Vigilant routine follow-up is needed for all patients
after EVAR.Early and long-term results of carotid endarterectomy in diabetic patients
Walter Dorigo, Raffaele Pulli, Giovanni Pratesi, Aaron Fargion, John Marek,
Alessandro Alessi Innocenti, Carlo Pratesi
Purpose: To evaluate results of carotid endarterectomy (CEA) in diabetic
patients in a large single-center experience.
Methods: Over a 13-year period ending in December 2008, 4305 consecutive
CEAs in 3573 patients were performed. All patients were prospectively
enrolled in a dedicated database. Interventions were performed in diabetic
patients in 883 cases (20.5%; group 1) and in nondiabetics in the remaining
3422 (79.5%; group 2). Early results in terms of 30-day stroke and death rates
were analyzed and compared. Follow-up results were analyzed with Kaplan-
Meier curves and compared with log-rank test.
Results: Diabetic patients were more likely to be females and to have coro-
nary artery disease, peripheral arterial disease, hyperlipemia, and arterial
hypertension than nondiabetics. There were no differences between the
two groups in terms of preoperative clinical status or degree of carotid
stenosis. Interventions were performed under general anesthesia with
somatosensory-evoked potentials (SEPs) monitoring in 67% of the patients
in both groups, while the remaining interventions were performed under
clinical monitoring. Shunt insertion (14% and 11%, respectively) and patch
closure rates (79% and 76%, respectively) were similar between the two
groups. There were no differences between the two groups in terms of
neurological outcomes, while the mortality rate was higher in group 1 than
in group 2 (P = .002; odds ratio [OR], 3.5; 95% confidence interval [CI], 1.5-
8.3); combined 30-day stroke and death rate was significantly higher in
group 1 (2%) than in group 2 (0.9%; P = .006; 95% CI, 1.2-3.9; OR, 2.2). At
138 Abstractsunivariate analysis, perioperative risk of stroke and death in diabetic
patients was significantly higher in patients undergoing intervention with
SEP cerebral monitoring (95% CI, 0.9-39.9; OR, 5.9; P = .01), and this was also
confirmed by multivariate analysis (95% CI, 1.1-23.1; OR, 8.3; P = .04). The
same analysis in nondiabetics demonstrated that again the need for general
anesthesia significantly increased perioperative risk, but this was not signif-
icant at multivariate analysis. Follow-up was available in 96% of patients,
with a mean duration of 40 months (range, 1-166 months). There were no
differences between the two groups in terms of estimated 7-year survival
(87.3% and 88.8%, respectively; 95% CI, 0.57-1.08; OR, 0.8) and stroke-free
survival (86.8% and 88.1%, respectively; 95% CI, 0.59-1.07; OR, 0.8). Diabetic
patients had decreased severe (>70%) restenosis-free survival rates at 7
years than nondiabetics (77.4% and 82.2%, respectively; 95% CI, 0.6-1; OR,
0.8; P = .05). Univariate analysis demonstrated again that the use of instru-
mental cerebral monitoring significantly decreased stroke-free survival in
diabetics (P = .01; log rank, 10.1), and this was also confirmed by multivar-
iate analysis (95% CI, 1.7-17.7; OR, 5.4; P = .005).
Conclusions: In our experience, the presence of diabetes mellitus increases
three-fold the risk of perioperative death after CEA, while there are no
differences with nondiabetics in terms of perioperative stroke. However,
the rate of stroke and death at 30 days still remains below the recommended
standards. During follow-up, this difference becomes negligible, and results
are fairly similar to those obtained in nondiabetics. Particular attention
should be paid to patients undergoing intervention under general anes-
thesia, who seem to represent a subgroup of diabetics at higher periopera-
tive risk, suggesting neurologic monitoring should be used when possible.Effects of statins on early and late results of carotid stenting
Fabio Verzini, Paola De Rango, Gianbattista Parlani, Giuseppe Giordano,
Valeria Caso, Enrico Cieri, Giacomo Isernia, Piergiorgio Cao
Objectives: Increasing data suggest that statins can significantly decrease
cardiovascular and cerebrovascular events due to a plaque stabilization
effect. However, the benefit of statins in patients undergoing carotid angio-
plasty and stenting (CAS) for carotid stenosis is not well defined. The aim of
this study was to investigate whether statins use was associated with
decreased perioperative and late risks of stroke, mortality, and restenosis
in patients undergoing CAS.
Methods: All patients undergoing CAS for primary carotid stenosis from 2004
to 2009 were reviewed. The independent association of statins and perio-
perative morbidity was assessed using multivariable analysis. Survival curves
and Cox regression models were used to assess late morbidity and restenosis.
Propensity score adjustment was employed.
Results: A total of 1083 consecutive CAS were performed (29% females,
mean age 71.5 years; 24.7% symptomatic); 465 (43%) were on statins medi-
cation before treatment that was not discontinued at discharge. Statins use
was associated with a reduction of perioperative stroke and death (odds
ratio [OR] 0.327, 95% confidence interval [CI] 0.13-0.80, P = .016) according
to multivariable analysis. Statins effect was more significant in reducing
stroke and death in symptomatic patients (OR 0.13; P = .032) and in males
(OR 0.27, P = .01). At 5 years, survival (87.2% vs 78.3%; P = .009) and ischemic
stroke-free interval (88.9% vs 99.7%; P = .02) rates were higher in the statins
group of patients. Adjusting for propensity score and covariates in Cox
regression analyses, statins use was independently associated with reduced
long-term mortality risk (HR 0.56, 95% CI 0.32-0.97; P = .039) and borderline
associated with decreased late ischemic stroke risk (HR 0.14; 95% CI 0.018-
1.08, P = .059). There was no effect on restenosis rates.
Conclusions: These data suggest that statins use is associated with
decreased perioperative and late ischemic strokes risk and reduced
mortality rates in patients undergoing CAS. Statins therapy should be consid-
ered part of the best medical treatment in current CAS practice.Total laparoscopic renal artery bypass for restenosis after failed
percutaneous transluminal renal stenting
Je´roˆme Cau, Jean Baptiste Ricco, Olivier Page, Gilles Re´gnault de la Mothe,
Christophe Marchand, Alexandre Valagier
Objective: The purpose of this article was to report our experience of the
repair of renal artery restenosis after percutaneous transluminal renalangioplasty (PTRA) using a total laparoscopic technique without robotic
assistance.
Methods: Between February 2005 and October 2009, we performed six total
laparoscopic aortorenal artery bypasses for restenosis after failed PTRA. All
these patients had recurrent hypertension with renal insufficiency.
Results: The mean operative time was 246 minutes (range, 200-310
minutes). The mean warm renal ischemic time was 28 minutes (range,
22-35 minutes). All patients received a prosthetic graft interposition. The
estimated surgical blood loss was 980 mL (range, 500-1400 mL). No conver-
sion was observed and no in-hospital deaths occurred. There was no severe
postoperative morbidity. Postoperative serum creatinine levels raised in all
patients but all returned to baseline before discharge. Median length of
postoperative hospital stay was 6 days (range, 4-8 days). Median follow-up
was 13 months (range, 7-19 months). Color Doppler ultrasound scan exami-
nation and computed tomography (CT) with injection of contrast media
showed patency of all bypasses. Hypertension was improved in all patients
but renal insufficiency remained unchanged.
Conclusion: Total laparoscopic renal artery bypass is feasible and safe in
patients after failed PTRA. This approach may reduce the morbidity of open
repair but is technically demanding and necessitates a large previous expe-
rience in total laparoscopic aortic surgery.Iliac vein stenting in postmenopausal leg swelling
Seshadri Raju, Matthew Oglesbee, Peter Negle´n
Background: Leg swelling in menopausal women is well known. Prevailing
concept in primary care is that it is polycentric and a treatable cause may
not be found. Patients are placed on empiric diuretics often without benefit.
Our clinical experience indicates that iliac venous vein obstruction is the
core cause; a variety of secondary factors common in postmenopausal
women precipitate symptoms.
Patients and Methods: A total of 163 limbs in 150 postmenopausal women
(55 years of age) with leg swelling unresponsive to conservative therapy
underwent intravascular ultrasound-guided iliac vein stenting over an 11-year
period. Preoperative investigations included duplex, airplethysmography,
venous pressure tests, contrast studies, and lymphangiography. The postmen-
opausal group constituted 9% of all limbs (n = 1760) stented for chronic venous
disease (CVD) during the same period and 18% of those stented for swelling (n
= 922). Median age was 67 (range, 55-92) and left-to-right ratio 2:1.
Results: Iliac vein obstruction was ‘‘primary’’ (nonthrombotic) in 65% and
postthrombotic in 35% of limbs; 35% of limbs had obstruction only and 65%
combined obstruction/reflux. Lymphatic dysfunction was present in 21% of
the limbs. Mean intravascular ultrasound area stenosis was 68%  22 SD.
Mean follow-up was 22 months (26 SD) (range, 1-113 months). Secondary
stent patency (6 years) was 100% in primary and 91% in postthrombotic
limbs; overall 98%. Swelling improved significantly (P < .0001) from preoper-
ative grade 2.5 (0.8 SD) to postoperative grade 1.2 (1.2 SD). Associated
pain also improved significantly (P < .0001) from preoperative visual analog
scale 3.5 (3 SD) to postoperative 0.9 (2.1  SD). Quality-of-life (CIVQ)
scores improved significantly in every category and overall (P < .0001).
Conclusions: Patients with postmenopausal leg swelling often have obstruc-
tive venous pathology even though suggestive venous history and other signs
are often absent. Morbidity arises from painful swelling that affects
mobility, quality of life, and ability of self-care at later stages of life. Outpa-
tient percutaneous iliac vein stenting affords substantial symptom relief and
improvement in quality-of-life measures. Recognition of the clinical complex
as a distinct entity of venous origin may lead to greater awareness and effec-
tive treatment.Clinical significance of cerebrovascular gas emboli during polidocanol
endovenous ultra-low nitrogen microfoam ablation and correlation with
magnetic resonance imaging in patients with right-to-left shunt
John D. Regan, Kathleen D. Gibson, Janet E. Rush, Cynthia K. Shortell,
Stanley A. Hirsch, David D.I. Wright
Background: Foam generated by manual agitation of liquid sclerosant with
air or gas is routinely utilized to treat refluxing veins. Although generally
well tolerated, serious neurological events have been reported. The compo-
sition and properties of the foam, including bubble size and gaseous
Abstracts 139components, may contribute to the potential for microcirculatory obstruc-
tion and cerebral ischemia. We tested an ultra-low nitrogen polidocanol en-
dovenous microfoam with controlled bubble size and density and
hypothesized that patients at risk due to the presence of middle cerebral
artery (MCA) bubble emboli during microfoam injection would not demon-
strate evidence of clinical or subclinical cerebral infarction.
Methods: Patients with great saphenous vein incompetence were treated
with ultra-low nitrogen (0.8%) polidocanol endovenous microfoam injected
under ultrasound guidance. Patients with right-to-left shunt were included
to evaluate the safety of cerebral arterial bubbles. All patients with MCA
emboli detected by transcranial Doppler during endovenous microfoam abla-
tion received intensive surveillance for microinfarction, including brain
magnetic resonance imaging and measurement of cardiac troponin-I.
Results: MCA bubble emboli were detected in 60 of 82 treated patients; 22
patients had no detectable emboli. Among patients with MCA bubbles de-
tected, 49 (82%) had15 bubbles. No patients developedmagnetic resonance
imaging abnormalities, neurological signs, or elevated cardiac troponin.
Conclusions: Patients treated with foamed liquid sclerosants are commonly
exposed to cerebrovascular gas bubbles. In this series of 60 high-risk patients
with MCA bubble emboli during or after treatment with ultra-low nitrogen
polidocanol endovenous microfoam, there was no evidence of cerebral or
cardiac microinfarction. The results of this study cannot be generalized to
foams compounded using bedside methodologies, since the composition of
these foams is substantially different.Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations
Yaowu Yang, Moyi Sun, Qin Ma, Xiaobing Cheng, Jianhua Ao, Lei Tian, Lei
Wang, Delin LeiObjectives: The purpose of this study was to document the results of bleo-
mycin A5 sclerotherapy for cervicofacial lymphatic malformations (LMs), and
the clinical data of 65 patients between October 2004 and October 2007
were reviewed.
Methods: Of the 65 patients in the study, 60 patients were given intrale-
sional injection of bleomycin A5. Five patients underwent partial resection,
and then an injection of bleomycin A5 for the remaining lesion. The
outcomes were assessed by physical examination and Doppler ultrasonog-
raphy scan. The follow-up time was from 6 months to 3 years after the last
injection (mean, 16 months).
Results: Among the 65 patients, 41 were men and 24 were women (1.7:1
male:female ratio), the age range was 3 months to 45 years (mean, 12
years). Thirty-two lesions (49%) were macrocystic, 30 (46%) were microcys-
tic, and 3 (5%) were combined. Each patient received 1 to 10 injections
(mean, 3.0 injections) for the whole course of treatment, and the total dose
of bleomycin A5 was from 8 to 80 milligrams (mean, 24.0 mg). Twenty-six of
32 macrocystic lesions (81%) showed greater than 90% reduction, whereas
another 6 (19%) exhibited 50% to 90% reduction. Nineteen of 30 microcystic
lesions (63%) showed greater than 90% reduction; 10 (33%) had 50% to 90%
reduction; and 1 (4%) had less than 50% size reduction. Of the 3 combined
lesions, 2 (67%) had greater than 90% shrinkage, and 1 (3%) had less than
50% reduction. The complications included ulceration of oral mucosa, minor
soft tissue atrophy, mild fever, and hematoma. There was no recurrence
throughout the follow-up period.
Conclusion: These data suggest bleomycin A5 is a safe and effective intra-
lesional agent for the treatment of macrocystic LMs, superficial oral mucosa
LM, and localized deep microcystic lesions. For extensive macrocystic LMs
involving contiguous anatomic areas and diffuse microcystic lesions
involving deep tissues, bleomycin A5 injection combined with resection is
necessary.
